Skip to main content
Skip to footer

The Future of Regulatory Intelligence with Conversational AI

Ashutosh Pachisia

Scientist, Research and Innovation, TCS ADD Platforms, TCS

Saurabh Das

Head, Research and Innovation, TCS ADD Platforms, TCS

Rohit Kadam

Researcher, Research and Innovation, TCS ADD Platforms, TCS

You have these already downloaded

We have sent you a copy of the report to your email again.

Advancement in technology and scientific research has increased the pace at which regulations change. In addition to regional regulatory requirements, pharmaceutical organizations need to comply with international regulations too. This changing landscape has resulted in several challenges for the life sciences industry.

In regulatory space, a regulatory professional performs various tasks such as maintaining files and data of various events for audit purposes and future reference, recommending strategies to achieve necessary compliance in the company, reporting compliance status, etc. These tasks can now be done by Conversational AI assistants (Chatbots) that offer human-like conversations and a better experience for users. Thus, expediating the process of intelligence gathering by using Nextgen technologies such as AI, graph database etc.

Read this article to understand how Chatbots can benefit regulatory landscape in the light of evolving standards and guidelines.

Read More

About the authors

Ashutosh Pachisia
Ashutosh Pachisia is a Data Scientist at Tata Consultancy Services (TCS). With nearly half a decade of experience in IT. He has a rich experience leading large complex programs and driving key initiatives for TCS Healthcare.
Read more about authorRead more about author Read more about author
Saurabh Das
Saurabh Das is part of Life Sciences, Advanced Drug Development (ADD) Platforms at Tata Consultancy Services (TCS). In his current role, he is the Product Manager of TCS' Pharmacovigilance Platform : Integrated Patient Safety. He has over 10 years of experience in product development and managing large program executions.
Read more about authorRead more about author Read more about author
Rohit Kadam
Rohit Kadam is a Researcher at Tata Consultancy Services (TCS). He is working with the TCS ADD Life Sciences Platform as a Researcher in R&I Team for nearly 2.5 years and contributed extensively in developing key solutions for TCS Healthcare Domain.
Read more about authorRead more about author Read more about author

Related reading

TCS ADD™ Alejandra Guerchicoff Narayanan R Tejas Almelkar

Transforming PV Efficiencies with ML and Rule-based Automation

White Paper | 18 Aug 2023
TCS ADD™ Prasoon Sangwan

Digital Data Flow and Technological Solution Providers

Article | 28 Jun 2023
TCS ADD™

Next-gen clinical trials on a digital platform

Customer Testimonial | 27 Jan 2023
TCS ADD™ Shalini Arora Niraj Vyas

Adopting a Design Thinking Approach for Risk-Based Monitoring

White Paper | 23 Dec 2022

Transformation starts here

Learn how we can help you bring drugs to the market faster.

Talk to our experts

Find out more